Related Experiment Video
Updated: Jun 9, 2026
07:59
Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Lung cancer genomic signatures
M Teresa Agulló-Ortuño1, Fernando López-Ríos, Luis Paz-Ares
1Servicio de Oncología, Hospital Universitario 12 de Octubre, Madrid, Spain. agullo@h12o.es
Summary
Genomic insights are revolutionizing lung cancer (LC) research, moving beyond traditional methods to identify subtypes and improve patient care. High-throughput technologies are crucial for understanding LC
Area of Science:
- Genomics
- Cancer Research
- Translational Medicine
Background:
- Lung cancer (LC) is a leading global cause of cancer mortality.
- Diagnosis often occurs at advanced stages, with limited effective treatments.
- Current clinicopathological classifications fail to capture the biological complexity of LC.
Purpose of the Study:
- To explore the application of high-throughput technologies in lung cancer research.
- To provide an overview of recent advancements in lung cancer genomics.
- To discuss the impact of genomic findings on patient care and future directions.
Main Methods:
- Utilizing genomic-based technologies and expression profiling.
- Analyzing high-throughput data for gene alterations in cancer.
- Reviewing current literature on lung cancer genomics.
Main Results:
- Genomic approaches enable identification of homogenous tumor subtypes.
- Discovery of new prognostic factors and prediction of treatment response.
- Advancements in discriminating tumors based on genetic background.
Conclusions:
- High-throughput technologies are transforming lung cancer research.
- Genomic insights offer potential for improved diagnostics, prognostics, and therapeutics.
- Continued research in LC genomics is essential for advancing patient care and overcoming challenges.
